Literature DB >> 34266856

Adiposity, Adulthood Weight Change, and Risk of Incident Hepatocellular Carcinoma.

Tracey G Simon1,2,3, Mi Na Kim3,4, Xiao Luo5,6, Xing Liu6,7, Wanshui Yang2,8,9, Yanan Ma2,5,8, Dawn Q Chong10,11, Charles S Fuchs12, Meir Stampfer2,6,8,13, Edward L Giovannucci2,6,8,13, Andrew T Chan1,2,3,8,14,15, Xuehong Zhang16,6,8.   

Abstract

Prospective data are limited regarding dynamic adulthood weight changes and hepatocellular carcinoma (HCC) risk. We included 77,238 women (1980-2012) and 48,026 men (1986-2012), who recalled young-adult weight [age 18 years (women); 21 years (men)], and provided biennially updated information regarding weight, body mass index (BMI), and comorbidities. Overall adulthood weight change was defined as the difference in weight (kilograms) between young-adulthood and present. Using Cox proportional hazards models, we calculated multivariable adjusted HRs (aHR) and 95% confidence intervals (CI). Over 3,676,549 person-years, we documented 158 incident HCC cases. Elevated HCC risk was observed with higher BMI in both young-adulthood and later-adulthood [continuous aHRs per each 1 unit = 1.05; 95% CI = 1.02-1.09 (P trend = 0.019), and 1.08; 95% CI = 1.06-1.10 (P trend = 0.004), respectively]. Moreover, overall adulthood weight gain was also significantly associated with increased HCC risk (aHR per each 1-kg increase = 1.03; 95% CI = 1.01-1.08; P trend = 0.010), including after further adjusting for young-adult BMI (P trend = 0.010) and later-adult BMI (P trend = 0.008). Compared with adults with stable weight (±5 kg), the multivariable-aHRs with weight gain of 5-<10 kg, 10-<20 kg, and ≥20 kg were, 1.40 (95% CI = 0.67-2.16), 2.09 (95% CI = 1.11-3.95), and 2.61 (95% CI = 1.42-5.22), respectively. In two prospective, nationwide cohorts, adulthood weight gain was significantly associated with increased HCC risk. PREVENTION RELEVANCE: Our data suggest that maintaining a stable weight during adulthood, specifically by preventing weight gain, could represent an important public health strategy for the prevention of hepatocellular carcinoma. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34266856      PMCID: PMC8492521          DOI: 10.1158/1940-6207.CAPR-20-0549

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  38 in total

Review 1.  Insulin resistance, obesity, and liver cancer.

Authors:  Geoffrey Farrell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

2.  Global trends and predictions in hepatocellular carcinoma mortality.

Authors:  Paola Bertuccio; Federica Turati; Greta Carioli; Teresa Rodriguez; Carlo La Vecchia; Matteo Malvezzi; Eva Negri
Journal:  J Hepatol       Date:  2017-03-21       Impact factor: 25.083

3.  Validity of self-reported waist and hip circumferences in men and women.

Authors:  E B Rimm; M J Stampfer; G A Colditz; C G Chute; L B Litin; W C Willett
Journal:  Epidemiology       Date:  1990-11       Impact factor: 4.822

4.  High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.

Authors:  Hannes Hagström; Per Tynelius; Finn Rasmussen
Journal:  Gut       Date:  2017-03-20       Impact factor: 23.059

5.  Rates of weight change for black and white Americans over a twenty year period.

Authors:  T J Sheehan; S DuBrava; L M DeChello; Z Fang
Journal:  Int J Obes Relat Metab Disord       Date:  2003-04

6.  Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals.

Authors:  S Chasan-Taber; E B Rimm; M J Stampfer; D Spiegelman; G A Colditz; E Giovannucci; A Ascherio; W C Willett
Journal:  Epidemiology       Date:  1996-01       Impact factor: 4.822

7.  Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Yanan Ma; Jonas F Ludvigsson; Dawn Q Chong; Edward L Giovannucci; Charles S Fuchs; Jeffrey A Meyerhardt; Kathleen E Corey; Raymond T Chung; Xuehong Zhang; Andrew T Chan
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

8.  Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.

Authors:  Tracey G Simon; Lindsay Y King; Dawn Q Chong; Long H Nguyen; Yanan Ma; Trang VoPham; Edward L Giovannucci; Charles S Fuchs; Jeffrey A Meyerhardt; Kathleen E Corey; Hamed Khalili; Raymond T Chung; Xuehong Zhang; Andrew T Chan
Journal:  Hepatology       Date:  2018-03-26       Impact factor: 17.425

9.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

Authors:  G A Colditz; P Martin; M J Stampfer; W C Willett; L Sampson; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

Review 10.  Exercise in cirrhosis: Translating evidence and experience to practice.

Authors:  Puneeta Tandon; Kathleen Patricia Ismond; Kenneth Riess; Andres Duarte-Rojo; Bandar Al-Judaibi; Michael Andrew Dunn; Jennifer Holman; Nancy Howes; Mark Joseph Franklin Haykowsky; Deborah Ann Josbeno; Margaret McNeely
Journal:  J Hepatol       Date:  2018-06-30       Impact factor: 25.083

View more
  2 in total

1.  Obesity and Risk of Liver and Biliary Tract Cancer: Does Timing and Trajectory Matter?

Authors:  Christie A Befort; Steven A Weinman
Journal:  JNCI Cancer Spectr       Date:  2022-08-09

2.  Body mass index trajectories, weight gain and risks of liver and biliary tract cancers.

Authors:  Wanshui Yang; Xufen Zeng; Jessica L Petrick; Christopher J Danford; Andrea A Florio; Bing Lu; Hongmei Nan; Jiantao Ma; Liang Wang; Hongmei Zeng; Staci L Sudenga; Peter T Campbell; Edward Giovannucci; Katherine A McGlynn; Xuehong Zhang
Journal:  JNCI Cancer Spectr       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.